Biologics are groundbreaking therapeutics that offer patients newer, more efficient, and safer treatment options. Upstream and downstream bioprocesses are constantly evolving to accelerate biopharmaceuticals from the discovery lab to the clinic. Bioprocess development and manufacturing of next-generation modalities require more advanced process analytical technologies (PAT) to obtain comprehensive data on critical product quality attributes and process parameters to increase robustness and throughput while reducing costs. 

Gain the process information you need using Waters innovations in LC, LC-MS, automation, and informatics. Bring mass spectrometry into your upstream and downstream bioprocess discovery, process development, and manufacturing to fully support your analytical needs from start to finish. 

• Increase your process understanding and develop more robust processes to support success at every phase 
• Gain comprehensive knowledge to accelerate process development  
• Optimize assets, resources and facilities to reduce operational costs